{"id":49986,"date":"2022-10-24T16:02:00","date_gmt":"2022-10-24T14:02:00","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/"},"modified":"2022-10-24T16:02:00","modified_gmt":"2022-10-24T14:02:00","slug":"global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/","title":{"rendered":"Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5650812\/global-syphilis-immunoassay-diagnostics-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=2vffs9&amp;utm_campaign=1766095+-+Global+Syphilis+Immunoassay+Diagnostics+Market+Report+2022%3A+Rising+Rate+of+Abortions%2C+Stillbirth%2C+and+other+Abnormalities+During+Pregnancy+Driving+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Syphilis Immunoassay Diagnostics Market (2022-2027) by Product, Technology, End-user, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221024005672\/en\/1611399\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221024005672\/en\/1611399\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global Syphilis Immunoassay Diagnostics Market is estimated to be worth USD 318 million in 2022, and is expected to reach USD 475.31 million by 2027, growing at a CAGR of 8.37%.\n<\/p>\n<p>\n<strong>Market Segmentation<\/strong>\n<\/p>\n<p>\nThe Global Syphilis Immunoassay Diagnostics Market is segmented based on Product, Technology, End-user, and Geography.\n<\/p>\n<ul>\n<li>\nBy Product, the market is classified into Analyzers, and Kits &amp; Reagents.\n<\/li>\n<li>\nBy Technology, the market is classified into ELISA, CLIA, and Others.\n<\/li>\n<li>\nBy End-user, the market is classified into Hospitals, Diagnostic Labs, Blood Banks, and Others.\n<\/li>\n<li>\nBy Geography, the market is classified into Americas, Europe, Middle-East &amp; Africa and Asia-Pacific.\n<\/li>\n<\/ul>\n<p>\n<strong>Company Profiles<\/strong>\n<\/p>\n<p>\nThe report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies&#8217; recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Danaher (Beckman Coulter), Roche, Siemens Healthineers, etc.\n<\/p>\n<p>\n<strong>Countries Studied<\/strong>\n<\/p>\n<ul>\n<li>\nAmerica (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)\n<\/li>\n<li>\nEurope (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)\n<\/li>\n<li>\nMiddle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)\n<\/li>\n<li>\nAsia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)\n<\/li>\n<\/ul>\n<p>\n<strong>The Competitive Quadrant<\/strong>\n<\/p>\n<p>\nThe report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.\n<\/p>\n<p>\n<strong>Ansoff Analysis<\/strong>\n<\/p>\n<ul>\n<li>\nThe report presents a detailed Ansoff matrix analysis for the Global Syphilis Immunoassay Diagnostics Market. Ansoff Matrix, also known as Product\/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.\n<\/li>\n<li>\nThe Global Syphilis Immunoassay Diagnostics Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.\n<\/li>\n<li>\nBased on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.\n<\/li>\n<\/ul>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\nDrivers\n<\/p>\n<ul>\n<li>\nRising Prevalence of Syphilis Infection Due to Unprotected Sex\n<\/li>\n<li>\nGovernment Reforms Targeted Towards the Betterment of Healthcare Infrastructure\n<\/li>\n<li>\nChances of Mother-to-Child Gestational Syphilis\n<\/li>\n<\/ul>\n<p>\nRestraints\n<\/p>\n<ul>\n<li>\nAsymptomatic Disease, and Problems in Diagnosing Very Early Syphilis\n<\/li>\n<\/ul>\n<p>\nOpportunities\n<\/p>\n<ul>\n<li>\nWidespread Use of Technology for Testing\n<\/li>\n<li>\nRising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy\n<\/li>\n<li>\nAvailability of Rapid, Automated Treponemal Tests and On-the-Spot Testing Solutions\n<\/li>\n<\/ul>\n<p>\nChallenges\n<\/p>\n<ul>\n<li>\nLack of Awareness of Syphilis Immunoassay Disease\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Report Description<\/strong>\n<\/p>\n<p>\n<strong>2 Research Methodology<\/strong>\n<\/p>\n<p>\n<strong>3 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4 Market Dynamics<\/strong>\n<\/p>\n<p>\n<strong>5 Market Analysis<\/strong>\n<\/p>\n<p>\n<strong>6 Global Syphilis Immunoassay Diagnostics Market, by Product<\/strong>\n<\/p>\n<p>\n<strong>7 Global Syphilis Immunoassay Diagnostics Market, by Technology<\/strong>\n<\/p>\n<p>\n<strong>8 Global Syphilis Immunoassay Diagnostics Market, by End User<\/strong>\n<\/p>\n<p>\n<strong>9 Americas&#8217; Syphilis Immunoassay Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>10 Europe&#8217;s Syphilis Immunoassay Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>11 Middle East and Africa&#8217;s Syphilis Immunoassay Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>12 APAC&#8217;s Syphilis Immunoassay Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>13 Competitive Landscape<\/strong>\n<\/p>\n<p>\n<strong>14 Company Profiles<\/strong>\n<\/p>\n<p>\n<strong>15 Appendix<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAbbott Laboratories\n<\/li>\n<li>\nBeckman Coulter\n<\/li>\n<li>\nBecton, Dickinson, and Company\n<\/li>\n<li>\nbioMerieux\n<\/li>\n<li>\nBio-Rad Laboratories\n<\/li>\n<li>\nDanaher (Beckman Coulter)\n<\/li>\n<li>\nDiaSorin\n<\/li>\n<li>\nFujirebio (Miraca Group)\n<\/li>\n<li>\nGold Standard Diagnostics\n<\/li>\n<li>\nNewmarket Biomedical\n<\/li>\n<li>\nNuGenerex Diagnostics\n<\/li>\n<li>\nOrtho Clinical Diagnostics (Carlyle Group)\n<\/li>\n<li>\nRoche\n<\/li>\n<li>\nShenzhen New Industries Biomedical Engineering\n<\/li>\n<li>\nSiemens Healthineers\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5650812\/global-syphilis-immunoassay-diagnostics-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=2vffs9&amp;utm_campaign=1766095+-+Global+Syphilis+Immunoassay+Diagnostics+Market+Report+2022%3A+Rising+Rate+of+Abortions%2C+Stillbirth%2C+and+other+Abnormalities+During+Pregnancy+Driving+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/9d3u5w<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;:&#x70;r&#x65;s&#115;&#x40;&#114;&#x65;&#115;&#x65;&#97;&#x72;c&#x68;a&#x6e;d&#109;&#x61;&#114;&#x6b;&#101;&#x74;&#115;&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#115;&#x73;&#64;&#x72;&#x65;&#115;&#x65;a&#114;&#x63;h&#97;&#x6e;&#100;&#x6d;a&#114;&#x6b;e&#116;&#x73;&#46;&#x63;&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Syphilis Immunoassay Diagnostics Market (2022-2027) by Product, Technology, End-user, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Syphilis Immunoassay Diagnostics Market is estimated to be worth USD 318 million in 2022, and is expected to reach USD 475.31 million by &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49986","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Syphilis Immunoassay Diagnostics Market (2022-2027) by Product, Technology, End-user, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Syphilis Immunoassay Diagnostics Market is estimated to be worth USD 318 million in 2022, and is expected to reach USD 475.31 million by ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-24T14:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221024005672\/en\/1611399\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-24T14:02:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/\"},\"wordCount\":708,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005672\\\/en\\\/1611399\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/\",\"name\":\"Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005672\\\/en\\\/1611399\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-24T14:02:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005672\\\/en\\\/1611399\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005672\\\/en\\\/1611399\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Syphilis Immunoassay Diagnostics Market (2022-2027) by Product, Technology, End-user, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Syphilis Immunoassay Diagnostics Market is estimated to be worth USD 318 million in 2022, and is expected to reach USD 475.31 million by ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-24T14:02:00+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221024005672\/en\/1611399\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth &#8211; ResearchAndMarkets.com","datePublished":"2022-10-24T14:02:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/"},"wordCount":708,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221024005672\/en\/1611399\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/","name":"Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221024005672\/en\/1611399\/21\/logo.jpg","datePublished":"2022-10-24T14:02:00+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221024005672\/en\/1611399\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221024005672\/en\/1611399\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-syphilis-immunoassay-diagnostics-market-report-2022-rising-rate-of-abortions-stillbirth-and-other-abnormalities-during-pregnancy-driving-growth-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Syphilis Immunoassay Diagnostics Market Report 2022: Rising Rate of Abortions, Stillbirth, and other Abnormalities During Pregnancy Driving Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49986"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49986\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}